Quinones-Hinojosa Alfredo, Raza Shaan M, Ahmed Ishrat, Rincon-Torroella Jordina, Chaichana Kaisorn, Olivi Alessandro
Neurosurgical Oncology Outcomes Laboratory, Department of Neurosurgery, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Brain Tumor Stem Cell Laboratory, Department of Neurosurgery and Oncology, 1550 Orleans Street, Cancer Research Building II Room 247, Baltimore, MD, 21231, USA.
Acta Neurochir Suppl. 2017;124:159-164. doi: 10.1007/978-3-319-39546-3_25.
High-grade astrocytomas of the mesial temporal lobe may pose surgical challenges. Several approaches (trans-sylvian, subtemporal, and transcortical) have been designed to circumnavigate the critical neurovascular structures and white fiber tracts that surround this area. Considering the paucity of literature on the transcortical approach for these lesions, we describe our institutional experience with transcortical approaches to Grade III/IV astrocytomas in the mesial temporal lobe.
Between 1999 and 2009, 23 patients underwent surgery at the Johns Hopkins Medical Institutions for Grade III/IV astrocytomas involving the mesial temporal lobe (without involvement of the temporal neocortex). Clinical notes, operative records, and imaging were reviewed.
Thirteen patients had tumors in the dominant hemisphere. All patients underwent surgery via a transcortical approach (14 via the inferior temporal gyrus and 9 via the middle temporal gyrus). Gross total resection was obtained in 92 % of the cohort. Neurological outcomes were: clinically significant stroke (2 patients), new visual deficits (2 patients), new speech deficit (1 patient); seizure control (53 %).
In comparison to reported results in the literature for the transylvian and subtemporal approaches, the transcortical approach may provide the access necessary for a gross total resection with minimal neurological consequences. In our series of patients, there was no statistically significant difference in outcomes between the middle temporal gyrus versus the inferior temporal gyrus trajectories.
颞叶内侧的高级别星形细胞瘤可能带来手术挑战。已设计了几种手术入路(经侧裂、颞下和经皮质)来避开该区域周围关键的神经血管结构和白质纤维束。鉴于关于这些病变经皮质入路的文献较少,我们描述了我们机构采用经皮质入路治疗颞叶内侧III/IV级星形细胞瘤的经验。
1999年至2009年期间,23例患者在约翰霍普金斯医疗机构接受了手术,治疗累及颞叶内侧(不累及颞叶新皮质)的III/IV级星形细胞瘤。回顾了临床记录、手术记录和影像学资料。
13例患者肿瘤位于优势半球。所有患者均采用经皮质入路手术(14例经颞下回,9例经颞中回)。该队列中92%的患者实现了肉眼下全切。神经功能转归如下:有临床意义的卒中(2例患者)、新出现的视觉缺损(2例患者)、新出现的言语缺损(1例患者);癫痫控制率为53%。
与文献报道的经侧裂和颞下入路的结果相比,经皮质入路可能提供实现肉眼下全切所需的入路,且对神经功能影响最小。在我们的患者系列中,经颞中回与经颞下回入路的结果在统计学上无显著差异。